AK119

AK119 Uses, Dosage, Side Effects, Food Interaction and all others data.

AK119 is a humanized anti-CD73 monoclonal antibody being investigated in the clinical trial NCT04516564 (A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects).

Trade Name	AK119
Generic	AK119
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

How AK119 works

AK119 binds to, and inhibits, human CD73 with high affinity. It was seen to result in CD73 internalization and promotion of IgG production from B cells in studies. This drug is currently being investigated as immunotherapy for COVID-19.

Innovators Monograph

You find simplified version here AK119